Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3530677rdf:typepubmed:Citationlld:pubmed
pubmed-article:3530677lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3530677lifeskim:mentionsumls-concept:C0013295lld:lifeskim
pubmed-article:3530677lifeskim:mentionsumls-concept:C0028978lld:lifeskim
pubmed-article:3530677lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3530677pubmed:issue8lld:pubmed
pubmed-article:3530677pubmed:dateCreated1986-11-7lld:pubmed
pubmed-article:3530677pubmed:abstractTextIn an open clinical trial, 16 hospital outpatients with endoscopically proven duodenal ulcer were given 30 mg omeprazole once daily for four weeks. After two weeks' treatment 14 of the 16 patients had healed and after four weeks all patients were healed. Reduction of pain was rapid and occurred during the first part of the trial. No serious adverse events or clinically significant deviations from normal laboratory values were reported. Serum gastrin levels significantly increased during treatment but returned to normal levels after the treatment was discontinued.lld:pubmed
pubmed-article:3530677pubmed:languageenglld:pubmed
pubmed-article:3530677pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3530677pubmed:citationSubsetIMlld:pubmed
pubmed-article:3530677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3530677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3530677pubmed:statusMEDLINElld:pubmed
pubmed-article:3530677pubmed:issn0378-6501lld:pubmed
pubmed-article:3530677pubmed:authorpubmed-author:VezzadiniPPlld:pubmed
pubmed-article:3530677pubmed:authorpubmed-author:TomassettiPPlld:pubmed
pubmed-article:3530677pubmed:authorpubmed-author:LabóGGlld:pubmed
pubmed-article:3530677pubmed:authorpubmed-author:JonssonEElld:pubmed
pubmed-article:3530677pubmed:authorpubmed-author:RinettiMMlld:pubmed
pubmed-article:3530677pubmed:issnTypePrintlld:pubmed
pubmed-article:3530677pubmed:volume12lld:pubmed
pubmed-article:3530677pubmed:ownerNLMlld:pubmed
pubmed-article:3530677pubmed:authorsCompleteYlld:pubmed
pubmed-article:3530677pubmed:pagination701-5lld:pubmed
pubmed-article:3530677pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:meshHeadingpubmed-meshheading:3530677-...lld:pubmed
pubmed-article:3530677pubmed:year1986lld:pubmed
pubmed-article:3530677pubmed:articleTitleEffect and tolerability of omeprazole in the treatment of duodenal ulcer disease.lld:pubmed
pubmed-article:3530677pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3530677pubmed:publicationTypeClinical Triallld:pubmed